Big Move Ventures (CEO Hoonjae Jeong) announced on the 2nd that it has invested in Cham Yak Sa, a leading company in pharmacy digital transformation.
Cham Yak Sa is a pharmacy chain MRO business and pharmacy IT solution development company. With this investment from Big Move Ventures, the company plans to enhance its IT solutions and expand its MRO business.
Jung Hoon-jae, CEO of Big Move Ventures, said, “Pharmacies are an important axis of the domestic pharmaceutical and bio ecosystem,” and added, “Big Move Ventures will continue to build the Bumin Care Networks system through strategic investments that consider synergy with the Bumin Hospital Group in 2025.”
In addition to this investment in pharmacy platform company Cham Yak Sa, Big Move Ventures has also participated in the discovery and investment of promising startups in the bio-healthcare field, such as Innoclas, a whole-genome analysis company, Promedius, an X-ray-based osteoporosis prediction company, and EverX, a company specializing in musculoskeletal digital rehabilitation treatment solutions.
Meanwhile, Big Move Ventures, celebrating its fourth anniversary this year, announced plans to accelerate the company's growth based on its established foundation.
Additionally, CIO Choi Hyeong-seop stated, “Big Move Ventures plans to form its third investment fund this year and diversify its investment opportunities and business collaborations through collaborations with various companies.”
- See more related articles
You must be logged in to post a comment.